col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


56 Results       Page 1

 [1] 
Elsevier: Human Immunology
  original article Date Title Authors   All Authors
1 [GO] 2025―May―26 The effects of SARS-CoV-2 vaccines on antinuclear autoantibody formation in individuals without prior COVID-19 infection Faruk Dişli, Yücehan Yılmaz, Sedat Yıldız
2 [GO] 2025―Feb―10 Association of IL10 gene SNVs rs1800896 (A>G), rs1800871 (C>T), rs1800872 (C>A) and haplotypes with COVID-19 severity and outcome in the Brazilian population Janaina Nicolau de Oliveira, Caroline Yukari Motoori Fernandes, Sara Mataroli de Godoy, Wilson Frantine-Silva, Pedro Luis Candido de Souza Cassela, Guilherme Lerner Trigo, et al. (+4)
3 [GO] 2025―Feb―07 Convalescent COVID-19 monocytes exhibit altered steady-state gene expression and reduced TLR2, TLR4 and RIG-I induced cytokine expression Sarah Unterberger, Nadia Terrazzini, Sandra Sacre
4 [GO] 2025―Jan―05 HLA-DQB1*05:03 is associated with an increased risk of COVID-19 progression in the Bulgarian population Tsvetelin Lukanov, Anastasiya Mihaylova, Bushra Al Hadra, Spaska Lesichkova, Atanaska Georgieva, Tsvetan Popov, et al. (+3)
5 [GO] 2024―Dec―11 Investigation of the circulatory microRNAs and their involvement in regulation of inflammation in patients with COVID-19 Mitra Abbasifard, Hamid Ostad Ebrahimi, Gholamhosein Taghipur Khajeh Sharifi, Fatemeh Bahrehmand, Zahra Bagheri-Hosseinabadi
6 [GO] 2024―Nov―20 ABO gene polymorphism and COVID-19 severity: The impact on haematological complications, inflammatory markers, and lung lesions Mohammad Samet, Parvane Raeesi Mahdiabadi, Masoud Tajamolian, Mohsen Gholinataj Jelodar, Kimia Monshizadeh, Reza Rafiei Javazm, et al. (+3)
7 [GO] 2024―Oct―16 Differential gene expression of immune response in COVID-19 and its relationship with progression of COVID-19 Yun-Xi Li, Yang-Cheng Wen, Zhen-Yue Li, Pei-Yu Ou
8 [GO] 2024―Sep―29 Genetic variations in Interferon-Induced with Helicase C Domain 1: Impact on COVID-19 risk and severity in the Moroccan population Safaa Aqillouch, Chaimaa Zerrad, Oumaima Laazaazia, Ahd Ouladlahsen, Kamal El Bissati, Khadija Akarid, et al. (+3)
9 [GO] 2024―Sep―13 COVID-19 vaccine side effects are associated with HLA-A*03:01 carriage and fewer breakthrough infections A. Srivastava, T. Yusufali, N. Peyser, G. Marcus, J. Olgin, M. Pletcher, et al. (+2)
10 [GO] 2024―Sep―13 HLA-C peptide repertoires as predictors of clinical response during early SARS-CoV-2 infection M. Olp, V. Laufer, A. Valesano, A. Zimmerman, K. Woodside, M. Najor, et al. (+3)
11 [GO] 2024―Sep―11 Seroconversion in liver and intestine transplant patients after one, two or three doses of adenoviral vector vaccines against SARS-CoV-2. Single center experience in Argentina Yantorno Silvina, Curciarello Renata, Rizzo Gastón, Ferreyra Compagnucci Malena, Tau Lorena, Delaplace Laura, et al. (+5)
12 [GO] 2024―Jun―27 Common human leucocyte antigensassociated with the development of subacute thyroiditis and COVID-19 Fatma Nur Korkmaz, Asena Gökçay Canpolat, Klara Dalva, Mustafa Şahin, Demet Çorapçıoğlu, Özgür Demir
13 [GO] 2024―Apr―11 Deregulated expression of autophagy genes; PIK3C3 and RAB7A in COVID-19 patients Mona Tahoun, Ahmed S. Sadaka
14 [GO] 2024―Apr―06 A comparative analysis of TCR immune repertoire in COVID-19 patients Xiao Zhu, Enze Ma, Ke Ning, Xiangyan Feng, Wei Quan, Fei Wang, et al. (+4)
15 [GO] 2024―Apr―05 HLA alleles associated with susceptibility and severity of the COVID-19 in Vietnamese Nguyen Thi Thanh Hai, Vu Phuong Nhung, Nguyen Thi Thanh Tam, Tran Thi Bich Ngoc, Ma Thi Huyen Thuong, Ha Van Dai, et al. (+5)
16 [GO] 2024―Mar―29 Role of HLA-G in tumors and upon COVID-19 infection Barbara Seliger
17 [GO] 2024―Mar―02 Investigating viral and autoimmune T cell responses associated with post-acute sequelae of COVID-19 Gregory P. Williams, Esther Dawen Yu, Kendra Shapiro, Eric Wang, Antoine Freuchet, April Frazier, et al. (+3)
18 [GO] 2024―Feb―02 Monitored COVID-19 vaccine humoral response in immunocompromised solid organ transplant recipients Afzal Nikaein, Ashley Chemmalakuzhy, Salman Khan, Judson Hunt, Derek Haumpy, Alok Choudhary, et al. (+3)
19 [GO] 2023―Sep―28 Coronavirus-19 disease risk and protective factors associated with HLA/KIR polymorphisms in Ecuadorian patients residing in Madrid Antonio Balas, Miguel Ángel Moreno-Hidalgo, Fernando de la Calle-Prieto, José Luis Vicario, Marta Arsuaga, Elena Trigo, et al. (+3)
20 [GO] 2023―Sep―25 P525 Cracking the code: Exploring the connection between COVID-19 vaccines and HLA antibodies in kidney transplant candidates D. Webster, T. Pearce, A. Mostafa, H. Pan, Y. Zhao, P. Kakodkar, et al. (+8)
21 [GO] 2023―Jun―05 Combining nano-curcumin with catechin improves COVID-19-infected patient's inflammatory conditions Talar Ahmad merza Mohammad
22 [GO] 2023―Apr―09 Expression of concern: “Humoral immune mechanisms involved in protective and pathological immunity during COVID-19” [Hum. Immunol. 82(10) (2021) 733-745] Gunawan Widjaja, Abduladheem Turki Jalil, Heshu Sulaiman Rahman, Walid Kamal Abdelbasset, Dmitry O. Bokov, Dmitry O. Bokov, et al. (+5)
23 [GO] 2023―Mar―14 Peripheral HLA-G/ILT-2 immune checkpoint axis in acute and convalescent COVID-19 patients Hana Rohn, Sabine Schramm, Krystallenia Pansikaki, Sarah Jansen, Celina Hendriks, Maximilian Platte, et al. (+9)
24 [GO] 2023―Feb―23 COVID-19 Infection and Vaccination Rarely Impact HLA Antibody Profile in Waitlisted Renal Transplant Candidates- A Multicenter Cohort Garrett R. Roll, Robert A. Bray, Matthew Cooper, Todd N. Eagar, Howard M. Gebel, Gayle M. Vranic, et al. (+20)
25 [GO] 2023―Feb―13 HLA-E*01:01+HLA-E*01:01 genotype confers less susceptibility to COVID-19, while HLA-E*01:03+HLA-E*01:03 genotype is associated with more severe disease Ehteramolsadat Hosseini, Arefeh Minagar, Mehran Ghasemzadeh, Ali Arabkhazaeli, Alireza Ghasemzadeh
26 [GO] 2023―Feb―06 Impact of HLA polymorphisms on the susceptibility to SARS-CoV-2 infection and related mortality in patients with renal replacement therapy Omer Faruk AKCAY, Haci Hasan YETER, Yasemin Unsal, Emre YASAR, Sevim GONEN, Ulver DERICI
27 [GO] 2023―Jan―20 The role of the HLA allelic repertoire on the clinical severity of COVID-19 in Canadians, living in the Saskatchewan province Pramath Kakodkar, Pouneh Dokouhaki, Fang Wu, Jay Shavadia, Revati Nair, Destinie Webster, et al. (+3)
28 [GO] 2022―Nov―07 Evaluation of serum soluble HLA-G levels post-recovery from COVID-19 and post-vaccination (Sinopharm and Pfizer-BioNTech) Roaa M. Hamed, Majid M. Mahmood, Ali H. Ad'hiah
29 [GO] 2022―Oct―11 In-silico study of influence of HLA heterogeneity on CTL responses across ethnicities to SARS-CoV-2 Vishal Rao, Nagasuma Chandra
30 [GO] 2022―Sep―12 HLA-B evolutionary divergence is associated with outcomes after SARS-CoV-2 infection Patricia V. Hernandez, Brian Duffy, Karl Hock, Christopher Farnsworth, Emily Schindler, Chang Liu
31 [GO] 2022―Aug―15 Association between SARS-CoV-2 infection and de novo HLA donor specific antibody production in lung transplant recipients: Single-center study Sadia Z. Shah, Yousif Abdelmoneim, Si M. Pham, Mohamed Elrefaei
32 [GO] 2022―Aug―08 Immunogenicity, effectiveness, safety and psychological impact of COVID-19 mRNA vaccines Alessio Alesci, Marco Gitto, Magdalena Kotańska, Patrizia Lo Cascio, Anthea Miller, Noemi Nicosia, et al. (+2)
33 [GO] 2022―Jul―14 Donor-directed immunologic safety of COVID-19 vaccination in renal transplant recipients Michael Kueht, Katie Kirk, A Scott Lea, Heather L Stevenson, Jeff Fair, A. Kathleen Gamilla-Crudo, et al. (+2)
34 [GO] 2022―Jun―21 Genetic variants in the NF-κB signaling pathway (NFKB1, NFKBIA, NFKBIZ) and risk of critical outcome among COVID-19 patients Daniel G. Camblor, Daniel Miranda, Guillermo M. Albaiceta, Laura Amado-Rodríguez, Elías Cuesta-Llavona, Daniel Vázquez-Coto, et al. (+4)
35 [GO] 2022―Apr―28 Distribution of HLA-A, -B, -C, -DRB1, -DQB1, -DPB1 allele frequencies in patients with COVID-19 bilateral pneumonia in russians, living in the chelyabinsk region (Russia) A. Suslova Tatiana, N. Vavilov Mikhail, V. Belyaeva Svetlana, V. Evdokimov Alexander, S. Stashkevich Daria, Galkin Alexander, A. Kofiadi Ilya
36 [GO] 2022―Mar―15 HLA-G 14-bp insertion/deletion polymorphism and risk of coronavirus disease 2019 (COVID-19) among Iraqi patients Ali H. Ad'hiah, Noor T. Al-Bayatee
37 [GO] 2022―Jan―10 Designing of a bispecific antibody against SARS-CoV-2 spike glycoprotein targeting human entry receptors DPP4 and ACE2 Rupal Ojha, Kiran Gurjar, Tadi Sai Ratnakar, Amit Mishra, Vijay Kumar Prajapati
38 [GO] 2021―Nov―10 Anti-AT1R autoantibodies and prediction of the severity of Covid-19 Franco Papola, Veronica Biancofiore, Chiara Angeletti, Alessandro Grimaldi, Anna Cecilia Carucci, Vincenza Cofini, et al. (+4)
39 [GO] 2021―Nov―04 Landscapes and dynamic diversifications of B-cell receptor repertoires in COVID-19 patients Haitao Xiang, Yingze Zhao, Xinyang Li, Peipei Liu, Longlong Wang, Meiniang Wang, et al. (+31)
40 [GO] 2021―Sep―27 HLA-B*15 predicts survival in Egyptian patients with COVID-19 Ahmed Samir Abdelhafiz, Asmaa Ali, Merhan A. Fouda, Douaa M. Sayed, Mahmoud M Kamel, Lamyaa Mohamed Kamal, et al. (+2)
41 [GO] 2021―Sep―08 Exhausted NK cells and cytokine storms in COVID-19: whether NK cell therapy could be a therapeutic choice Mehran Ghasemzadeh, Ehteramolsadat Hosseini, Alireza Ghasemzadeh
42 [GO] 2021―Aug―21 HLA repertoire of 115 UAE nationals infected with SARS-CoV-2 Halima Alnaqbi, Guan K. Tay, Herbert F. Jelinek, Amirtharaj Francis, Eman Alefishat, Sarah El Haj Chehadeh, et al. (+6)
43 [GO] 2021―Jul―16 Soluble HLA-G is upregulated in serum of patients with severe COVID-19 Noor T. Al-Bayatee, Ali H. Ad'hiah
44 [GO] 2021―Jul―13 HLA-DRB1*04 may predict the severity of disease in a group of Iranian COVID-19 patients Samaneh Ebrahimi, Hamid Reza Ghasemi-Basir, Mohammad Mahdi Majzoobi, Ashkan Rasouli-Saravani, Mehrdad Hajilooi, Ghasem Solgi
45 [GO] 2021―Jul―09 HLA B53 is associated with a poor outcome in black COVID-19 patients Allen J. Norin, Rachelle Mendoza, Michael Augenbraun, Ballabh Das
46 [GO] 2021―Jul―01 Humoral immune mechanisms involved in protective and pathological immunity during COVID-19 Gunawan Widjaja, Abduladheem Turki Jalil, Heshu Sulaiman Rahman, Walid Kamal Abdelbasset, Dmitry O. Bokov, Wanich Suksatan, et al. (+5)
47 [GO] 2021―May―18 Chemotherapy vs. Immunotherapy in combating nCOVID19: An update Abhigyan Choudhury, Gargi Mukherjee, Suprabhat Mukherjee
48 [GO] 2021―May―10 Antigen presentation in sars-cov-2 infection: the role of class i hla and erap polymorphisms Irma Saulle, Chiara Vicentini, Mario Clerici, Mara Biasin
49 [GO] 2021―Apr―21 Risk HLA alleles in South America and potential new epitopes for SARS-CoV2 Samantha Sáenz Hinojosa, Vanessa Romero
50 [GO] 2021―Apr―17 COVID-19 Does Not Impact HLA Antibody Profile in a Series of Waitlisted Renal Transplant Candidates Garrett R. Roll, Tyler Lunow-Luke, Hillary J. Braun, Owen Buenaventura, Mirelle Mallari, Peter G. Stock, Raja Rajalingam
51 [GO] 2021―Jan―20 Predictive immunogenetic markers in COVID-19 Mauro de Meira Leite, Faviel F. Gonzalez-Galarza, Bruno Conde Costa da Silva, Derek Middleton, Eduardo José Melo dos Santos
52 [GO] 2021―Jan―20 Pharmacological approach for the reduction of inflammatory and prothrombotic hyperactive state in COVID-19 positive patients by acting on complement cascade A. Vitiello, R. La Porta, V. D'Aiuto, F. Ferrara
53 [GO] 2020―Dec―26 Dynamic changes in monocytes subsets in COVID-19 patients Shuang Qin, Yujie Jiang, Xin Wei, Xiaoyuan Liu, Jingjing Guan, Yingxiao Chen, et al. (+4)
54 [GO] 2020―Oct―07 Puzzling out the COVID-19: Therapy targeting HLA-G and HLA-E Inès Zidi
55 [GO] 2020―Sep―17 Characteristics of immune cells and cytokines in patients with coronavirus disease 2019 in Guangzhou, China Xing Chen, Jide Huang, Ying Huang, Jiabin Chen, Yingyi Huang, Xiaowen Jiang, Yaling Shi
56 [GO] 2020―Aug―13 Conserved hla binding peptides from five non-structural proteins of sars-cov-2-an in silico glance Jose Marchan
 [1] 

56 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec